Related Experiment Video

Updated: May 12, 2026

Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients
03:47

Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients

Published on: July 12, 2024

[Management of heart failure: a challenge for healthcare systems]

Michel Komajda1

  • 1Institut de cardiologie, Groupe Hospitalier Pitié Salpêtrière, 47/83, Boulevard de l'Hôpital--75013 Paris. michel.komadja@psl.aphp.fr

Bulletin De L'Academie Nationale De Medecine
|April 20, 2013
PubMed

Insights

Heart failure treatments have advanced for reduced ejection fraction but not for acute or preserved ejection fraction heart failure. New therapies are under development to improve patient outcomes and reduce healthcare burdens.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Heart failure is a widespread condition leading to high mortality, frequent hospitalizations, and disability.
  • Significant therapeutic advancements have been achieved for chronic heart failure with reduced ejection fraction (HFrEF).
  • Treatments for acute heart failure (AHF) and heart failure with preserved ejection fraction (HFpEF) remain limited.

Purpose of the Study:

  • To review the current state of heart failure management.
  • To highlight the progress in HFrEF treatment.
  • To emphasize the unmet needs in AHF and HFpEF management and the development of novel therapeutic strategies.

Main Methods:

  • Review of existing literature on heart failure treatments.
  • Analysis of therapeutic advancements in different heart failure subtypes.
  • Discussion of emerging treatment modalities.

Main Results:

  • Established neuromodulators (ACE inhibitors, beta-blockers, ARBs, MRAs) and ivabradine have improved outcomes in HFrEF.
  • Limited progress has been made in treating AHF and HFpEF.
  • Novel drugs, devices, and approaches are being investigated for these challenging conditions.

Conclusions:

  • While HFrEF management has seen substantial progress, effective treatments for AHF and HFpEF are still lacking.
  • Ongoing research into new therapies is crucial for reducing morbidity, mortality, and the significant healthcare burden associated with heart failure.
  • Future directions include exploring innovative drugs, devices, and other interventions to improve quality of life for all heart failure patients.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...